Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	23.4	23.63	17.11	38.99	18.27	17.79
Short-Term Investments	21.63	20.93	5.07	-	20.28	-
Cash & Short-Term Investments	45.03	44.56	22.18	38.99	38.55	17.79
Cash Growth	-6.55%	100.90%	-43.11%	1.14%	116.64%	-52.94%
Accounts Receivable	10.13	5.27	4.59	3.44	2	4.7
Other Receivables	-	0.48	0.36	0.31	0.77	0.63
Receivables	10.13	5.75	4.95	3.75	2.77	5.33
Inventory	20.72	19.05	16.8	17.95	13.08	8.16
Prepaid Expenses	-	0.44	0.77	0.91	0.84	0.31
Other Current Assets	1.49	0.13	0.17	0.07	0.48	0.89
Total Current Assets	77.37	69.93	44.88	61.67	55.72	32.48
Property, Plant & Equipment	10.34	10.88	9.64	9.92	10.41	10.95
Long-Term Deferred Tax Assets	3.3	3.09	-	-	-	-
Other Long-Term Assets	0.54	0.53	1.27	2.08	1.8	1.96
Total Assets	91.54	84.43	55.79	73.67	67.93	45.39
Accounts Payable	4.06	4.32	5.86	6.99	7.22	6.5
Accrued Expenses	13.3	13.2	11.6	16.34	13.61	11.81
Current Portion of Long-Term Debt	20.42	20.25	-	-	58.51	4.3
Current Portion of Leases	1.45	1.41	1.12	1.21	1.42	1.14
Current Income Taxes Payable	2.88	2.88	0.53	-	-	-
Current Unearned Revenue	12.7	-	13.18	8.55	5.39	16.34
Other Current Liabilities	3.17	3.48	0.14	0.1	0.32	0.1
Total Current Liabilities	57.97	45.53	32.43	33.18	86.47	40.18
Long-Term Debt	-	-	28.19	27.89	-	50.96
Long-Term Leases	4.28	4.62	4.17	4.38	4.47	4.53
Long-Term Unearned Revenue	-	-	-	11.79	1.72	16.98
Other Long-Term Liabilities	-	-	-	-	0.05	0.51
Total Liabilities	62.96	50.87	66.43	79.7	94.97	115.71
Common Stock	0.07	0.07	0.05	0.05	0.04	0.02
Additional Paid-In Capital	416.63	415.05	379.17	368.85	320.28	270.49
Retained Earnings	-388.12	-381.55	-389.86	-374.93	-347.35	-340.83
Shareholders' Equity	28.58	33.57	-10.64	-6.04	-27.04	-70.32
Total Liabilities & Equity	91.54	84.43	55.79	73.67	67.93	45.39
Total Debt	26.15	26.28	33.47	33.47	64.4	60.93
Net Cash (Debt)	18.88	18.28	-11.29	5.52	-25.86	-43.13
Net Cash Per Share	0.26	0.22	-0.23	0.12	-0.89	-2.91
Filing Date Shares Outstanding	73.54	73.05	57.35	46.32	45.38	14.84
Total Common Shares Outstanding	73.29	72.95	53.79	45.56	34.77	14.84
Working Capital	19.4	24.4	12.45	28.49	-30.75	-7.7
Book Value Per Share	0.39	0.46	-0.20	-0.13	-0.78	-4.74
Tangible Book Value	28.58	33.57	-10.64	-6.04	-27.04	-70.32
Tangible Book Value Per Share	0.39	0.46	-0.20	-0.13	-0.78	-4.74
Machinery	-	22.02	21.32	20.96	20.11	19.49
Leasehold Improvements	-	17.64	16.92	16.76	16.66	16.49

Source: S&P Capital IQ. Standard template. Financial Sources.